Regeneron Pharmaceuticals (REGN) Cash from Investing Activities Growth (5y) (2014 - 2026)
Regeneron Pharmaceuticals (REGN) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.54% |
| Dec 31, 2025 | 22.18% |
| Sep 30, 2025 | 12.28% |
| Jun 30, 2025 | -22.45% |
| Mar 31, 2025 | 28.19% |
| Dec 31, 2024 | 29.77% |
| Sep 30, 2024 | -22.64% |
| Jun 30, 2024 | 7.79% |
| Mar 31, 2024 | -16.80% |
| Dec 31, 2023 | 24.28% |
| Sep 30, 2023 | -11.60% |
| Jun 30, 2023 | -37.54% |
| Mar 31, 2023 | 11.14% |
| Dec 31, 2022 | -40.80% |
| Sep 30, 2022 | 20.45% |
| Jun 30, 2022 | -19.42% |
| Mar 31, 2022 | -64.83% |
| Dec 31, 2021 | -49.31% |
| Sep 30, 2021 | -43.14% |
| Jun 30, 2021 | 19.00% |